期刊
INTERNATIONAL JOURNAL OF CANCER
卷 135, 期 3, 页码 598-610出版社
WILEY
DOI: 10.1002/ijc.28703
关键词
RAS; BRAF; prognostic markers; methylation; well-differentiated thyroid cancer
类别
资金
- Fondo de Investigaciones Sanitarias [PI11/01359, FIS PI11/02421, PI11/01354, PI12/00236]
- Fundacion Mutua Madrilena [AP2775/2008]
- Comunidad de Madrid [S2011/BMD-2328 TIRONET]
- la Caixa/CNIO international PhD programme
- Spanish Ministry of Economy and Competitiveness (FPI program)
- Spanish Ministry of Economy and Competitiveness [SAF2011/23638, PTA2011-5655-I]
- CIBERER
- European Foundation for the Study of Diabetes [BI 2014_6_clinical] Funding Source: researchfish
Thyroid cancer is a heterogeneous disease with several subtypes characterized by cytological, histological and genetic alterations, but the involvement of epigenetics is not well understood. Here, we investigated the role of aberrant DNA methylation in the development of well-differentiated thyroid tumors. We performed genome-wide DNA methylation profiling in the largest well-differentiated thyroid tumor series reported to date, comprising 83 primary tumors as well as 8 samples of adjacent normal tissue. The epigenetic profiles were closely related to not only tumor histology but also the underlying driver mutation; we found that follicular tumors had higher levels of methylation, which seemed to accumulate in a progressive manner along the tumorigenic process from adenomas to carcinomas. Furthermore, tumors harboring a BRAF or RAS mutation had a larger number of hypo- or hypermethylation events, respectively. The aberrant methylation of several candidate genes potentially related to thyroid carcinogenesis was validated in an independent series of 52 samples. Furthermore, through the integration of methylation and transcriptional expression data, we identified genes whose expression is associated with the methylation status of their promoters. Finally, by integrating clinical follow-up information with methylation levels we propose etoposide-induced 2.4 and Wilms tumor 1 as novel prognostic markers related to recurrence-free survival. This comprehensive study provides insights into the role of DNA methylation in well-differentiated thyroid cancer development and identifies novel markers associated with recurrence-free survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据